theheart.org: Interventional Surgery news and studies. Duke and Mayo partnership.

Interventional/Surgery

VELETI in print: Plaque sealing of SVGs a strategy "ahead of its time"?

Nov 4, 2009 15:30 EST

The imaging study was the first to show that stenting a non-flow-limiting stenosis of an SVG may help slow or halt the accelerated atherosclerosis that takes place in these vessels. An accompanying editorial cautions that the study does little more than "infer a trend toward anatomic benefit."

Dallas, TX - Results of the ambitious and controversial "plaque-sealing" VELETI trial, looking at prophylactic use of paclitaxel-eluting stents in non-flow-limiting stenoses of saphenous vein grafts (SVGs), has now been published online November 2, 2009 in Circulation [1], accompanied by an editorial calling the strategy "ahead of its time [2]." Read full article »

Inside: Interventional/Surgery

Accredited educational programs, supported by industry, developed by theheart.org

Interventional/Surgery

Revascularization in Patients With Diabetes

Oct 7, 2009 14:12 EDT

Since BARI, CABG has been the gold standard for patients with diabetes and multivessel disease. However, SYNTAX suggests an increasing role for PCI and BARI 2D highlights the importance of optimal medical therapy. Dr. Boden leads a multidisciplinary discussion with Drs. Holmes and Taggart.

Interventional/Surgery

Dual Antiplatelet Therapy: Dueling Options in Real-World Practice

1 COMMENT - Sep 30, 2009 13:31 EDT

With the recent approval of a third-generation thienopyridine, choice of agent can be added to the list of considerations in the management of ACS patients, as well as the appropriate timing and dosing of thienopyridine. Using some case vignettes, Dr. King leads a discussion with Drs. Bhatt and Steg on their clinical decision-making.

Interventional/Surgery

Emerging Stent Technologies: Adding Innovation and New Science to Clinical Practice

Oct 20, 2009 13:38 EDT

Dr. Dean Kereiakes leads an international panel of experts, Drs. Meredith, Banning, and Hermiller, as they discuss fascinating developments in stent and polymer technology and design their "dream stent."

Interventional/Surgery

There's Triple Vessel Disease and Triple Vessel Disease: Risk Assessment

2 COMMENTS - Jun 22, 2009 08:08 EDT

How do the results of the SYNTAX trial impact clinical practice now? Join Drs. Banning and Hill as they present a complex case taken directly from the SYNTAX trial and discuss how new data will impact their choice of treatment, and listen to an overview of the trial presented by Dr. William Wijns.

Interventional/Surgery

TAVI vs AVR Patient Selection

Oct 27, 2009 14:49 EDT

The PARTNER and PAVIS trials of transcatheter aortic valve implementation will include inoperable or very high-surgical-risk patients. In Europe, where the devices have been approved for a few years, the technology is being expanded to lesser-risk patients. Interventionalist Dr Jeffrey Popma discusses the selection of patients with surgeon Dr Mathew Williams.

Interventional/Surgery

Transcatheter Aortic Valves: Lessons From Europe

Jun 26, 2009 00:02 EDT

Transcatheter aortic valve implantation (TAVI) has been approved in Europe since 2007, whereas these devices are just entering large-scale research trials in the United States. Dr. Popma leads a panel discussion with European interventionalist Dr. Eberhard Grube and surgeon Dr. Neil Moat on their experiences with TAVI.

Interventional/Surgery

Drug-Eluting Stents: Head-to-Head Clinical Trial Results

Nov 6, 2009 13:09 EST

How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.

Interventional/Surgery

Drug-Eluting Stents: Head-to-Head Clinical Trial Results

Oct 16, 2009 11:06 EDT

How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.

Clinical cardiology

New Data on Polyvascular Disease and ACS

1 COMMENT - Jun 23, 2009 09:40 EDT

Recently published data suggest that prior polyvascular disease increases the risk for inhospital adverse events in patients with ACS. Join Drs. Deepak Bhatt, Jean-Pierre Bassand, and José R. Gonzalez-Juanatey for a discussion of the current data on identification and management of patients with polyvascular disease.

Clinical cardiology

Combination Therapy and Cardiovascular Events: A Neurologist's Perspective

1 COMMENT - Jun 17, 2009 11:48 EDT

AF can lead to stroke, congestive heart failure, and other serious complications. Successful management should include reducing these risks. Join our expert panel, Drs. Peter Rothwell, Donald Easton, and Mark Alberts, as they discuss new data and strategies for improving outcomes in patients with AF.

Clinical cardiology

2009 Antiplatelet Debate: What's New in ACS

5 COMMENTS - Jun 12, 2009 15:03 EDT

Despite modern therapy, the rates of death, MI, bleeding, and readmission remain high in patients with ACS. Join Drs. Jeffery Popma, Héctor Bueno, Freek Verheugt, and Sunil. Rao for a review of the latest data on antiplatelet therapy for patients with ACS.

Interventional/Surgery

Interventional cardiologist Donald Baim dies

7 COMMENTS - Nov 6, 2009 18:22 EST

Interventional cardiologist, Dr Donald Baim, chief medical and scientific officer at Boston Scientific, has died.

Acute Coronary Syndromes

Latest European and US STEMI guidelines compared and contrasted

Nov 6, 2009 17:15 EST

The latest recommendations for the treatment of ST-elevation MI issued by American cardiology associations and the European Society of Cardiology are compared and contrasted in a new paper.

Interventional/Surgery

Off-pump CABG shows no benefit over on-pump approach: ROOBY study

7 COMMENTS - Nov 4, 2009 17:00 EST

A 2203-patient randomized trial of off-pump vs on-pump CABG surgery found no differences in neuropsychological outcomes and worse overall outcomes for the off-pump group at one-year follow-up.

heartbriefs

No CV risk reduction with B vitamins posttransplant

Nov 4, 2009 13:15 EST

In keeping with all the other evidence showing no effects of homocysteine-lowering with B vitamins, the FAVORIT study now confirms that this lack of benefit is also seen in renal-transplant recipients.

MediaPulse

Interventional cardiologist sues hospital under Whistleblower's Act

13 COMMENTS - Nov 3, 2009 15:15 EST

Dr David Gossman has filed a lawsuit claiming that he was fired for complaining about ties between the hospital and some of its senior staff with the medical device company Medtronic.

Interventional/Surgery

US updates advice on perioperative beta-blocker use in noncardiac surgery

5 COMMENTS - Nov 3, 2009 14:30 EST

A US update on the perioperative use of beta blockers for noncardiac surgery is, says the lead author, "similar" to recent European guidance on this issue.

Interventional/Surgery

Blood type of pig may be factor in longevity of porcine replacement heart valves

Oct 30, 2009 16:45 EDT

Researchers in Ottawa find that the longevity of porcine replacement heart valves may depend partly on whether the blood type of the patient matches the blood type of the valve's "original owner."

Interventional/Surgery

Underutilization of ICDs in CABG patients is worst in women and elderly, Halifax study shows

1 COMMENT - Oct 28, 2009 16:45 EDT

Only 101 of 1169 post-bypass-surgery patients eligible for an ICD got one over a 13-year period in Nova Scotia.

Acute Coronary Syndromes

Bariatric surgery fails to reduce risk of MI long term

1 COMMENT - Oct 28, 2009 14:30 EDT

After a median follow-up of 12 years, MI rates were essentially the same among those treated with surgery and those who received conventional care for weight loss.

Acute Coronary Syndromes

Contrary to common belief, women feel same heart-attack symptoms as men

4 COMMENTS - Oct 27, 2009 14:30 EDT

Women and men have the same rates of chest pain and other classic symptoms during ACS, although women are more likely to experience some other symptoms such as jaw and neck pain.

Interventional/Surgery

Stent pioneer Julio Palmaz urges DES makers to "learn from mistakes of the past"

1 COMMENT - Oct 27, 2009 13:00 EDT

Speaking at the 30th anniversary of the GISE Congress, Palmaz said he'd never believed drug elution was the way forward for stents and outlined his theories for why coatings of any kind disrupt the healing properties of metallic coronary stents.

View all »

Editorial Programs

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Bob Harrington

Nov 6, 2009 09:50 EST

Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.

Editorial series

Clinical research: Comparing regulatory pathways in US and UK

Oct 30, 2009 12:35 EDT

How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Peter Sleight

2 COMMENTS - Oct 13, 2009 10:15 EDT

With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.

	Yes
	No